abstract |
The invention relates to compounds of formula (see formula) wherein the substituents are described in claim 1. The compounds can be used in the treatment of diseases based on the glycine reuptake inhibitor, such as psychosis, pain, loss. neurodegenerative memory and learning, schizophrenia, dementia and other diseases in which cognitive procedures are damaged, such as attention deficit disorders or Alzheimer's disease. |